{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:06:31Z","timestamp":1790960791687,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The T cell immunoglobulin and mucin-domain receptor 3 (TIM-3) is an immune checkpoint receptor with complex effects on T cell activation and tolerance. TIM-3 is expressed on the surface of T cells in close proximity to the T cell receptor (TCR), where it mainly acts co-inhibitory, despite lacking typical inhibitory immunoreceptor inhibition motifs, to regulate T cell activity or apoptosis. However, the underlying molecular mechanisms of its intracellular signal transduction remains incompletely understood. Central for the function of TIM-3 are conserved cytoplasmic tyrosine structures that require phosphorylation for downstream signaling. Previous findings suggest that several kinases linked to TCR signaling, including the Src family kinase Lck and the Tec kinase ITK can interact with TIM-3 and thereby regulate TCR signaling and fine-tune T cell activation and tolerance. The ligand-dependent phosphorylation of TIM-3 by ITK, together with the displacement of the adapter protein Bat3, illustrates how TIM-3 signaling modulates early TCR activation. In this review, we describe the interactions of TIM-3 and its various actors that can trigger TCR signaling. This review also aims to shed light on this complex network by providing an overview of the immune checkpoint receptor TIM-3 and its influence on various autoimmune diseases. The focus here is clearly on inflammatory bowel disease (IBD), and open questions about the TIM-3 network are outlined.<\/jats:p>","DOI":"10.1007\/s00109-025-02631-z","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:09:59Z","timestamp":1767424199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of the TIM-3 receptor in inflammatory bowel disease and autoimmunity: implications for TIM-3 and TCR crosstalk"],"prefix":"10.1007","volume":"104","author":[{"given":"M.","family":"Gabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Knauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-0844","authenticated-orcid":false,"given":"B.","family":"Weigmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"Suppl 2","key":"2631_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0278-1","volume":"14","author":"JS Marshall","year":"2018","unstructured":"Marshall JS et al (2018) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 14(Suppl 2):49","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"Suppl 12","key":"2631_CR2","first-page":"5","volume":"2012","author":"BK Gorentla","year":"2012","unstructured":"Gorentla BK, Zhong XP (2012) T cell receptor signal transduction in T lymphocytes. J Clin Cell Immunol 2012(Suppl 12):5","journal-title":"J Clin Cell Immunol"},{"issue":"4","key":"2631_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1365-2567.2002.01391.x","volume":"105","author":"DA Cantrell","year":"2002","unstructured":"Cantrell DA (2002) T-cell antigen receptor signal transduction. Immunology 105(4):369\u2013374","journal-title":"Immunology"},{"issue":"2","key":"2631_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tibs.2017.11.008","volume":"43","author":"AH Courtney","year":"2018","unstructured":"Courtney AH, Lo WL, Weiss A (2018) TCR signaling: mechanisms of initiation and propagation. Trends Biochem Sci 43(2):108\u2013123","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"2631_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13(4):227\u2013242","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2631_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","volume":"57","author":"N Joller","year":"2024","unstructured":"Joller N, Anderson AC, Kuchroo VK (2024) LAG-3, TIM-3, and TIGIT: distinct functions in immune regulation. Immunity 57(2):206\u2013222","journal-title":"Immunity"},{"issue":"6871","key":"2631_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney L et al (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415(6871):536\u2013541","journal-title":"Nature"},{"key":"2631_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115583","volume":"212","author":"M Wu","year":"2023","unstructured":"Wu M et al (2023) Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy. Biochem Pharmacol 212:115583","journal-title":"Biochem Pharmacol"},{"key":"2631_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000911","author":"N Acharya","year":"2020","unstructured":"Acharya N, Sabatos-Peyton C, Anderson AC (2020) Tim-3 finds its place in the cancer immunotherapy landscape. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-000911","journal-title":"J Immunother Cancer"},{"issue":"3","key":"2631_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-024-01667-z","volume":"44","author":"A Baldrich","year":"2024","unstructured":"Baldrich A et al (2024) Post-transplant inflammatory bowel disease associated with donor-derived TIM-3 deficiency. J Clin Immunol 44(3):1\u201310","journal-title":"J Clin Immunol"},{"issue":"12","key":"2631_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu C et al (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6(12):1245\u20131252","journal-title":"Nat Immunol"},{"issue":"10","key":"2631_CR12","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1073\/pnas.1712107115","volume":"115","author":"L Avery","year":"2018","unstructured":"Avery L et al (2018) Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion. Proc Natl Acad Sci U S A 115(10):2455\u20132460","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2631_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","volume":"20","author":"Y Wolf","year":"2020","unstructured":"Wolf Y, Anderson AC, Kuchroo VK (2020) TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol 20(3):173\u2013185","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2631_CR14","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.2871","volume":"18","author":"M Rangachari","year":"2012","unstructured":"Rangachari M et al (2012) Bat3 promotes T cell responses and autoimmunity by repressing Tim-3\u2013mediated cell death and exhaustion. Nat Med 18(9):1394\u20131400","journal-title":"Nat Med"},{"issue":"2","key":"2631_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbrc.2006.10.079","volume":"351","author":"PS van de Weyer","year":"2006","unstructured":"van de Weyer PS et al (2006) A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun 351(2):571\u2013576","journal-title":"Biochem Biophys Res Commun"},{"key":"2631_CR16","doi-asserted-by":"publisher","unstructured":"Huang Y-H et al (2015) CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 517(7534): p. 386\u2013390. corrigendum: https:\/\/doi.org\/10.1038\/nature17421","DOI":"10.1038\/nature17421"},{"key":"2631_CR17","unstructured":"Consortium TU (2022) UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res 51(D1): p. D523\u2013D531."},{"key":"2631_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","author":"M Uhlen","year":"2015","unstructured":"Uhlen M et al (2015) Tissue-based map of the human proteome. Science. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"issue":"3","key":"2631_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.immuni.2007.03.004","volume":"26","author":"AC Anderson","year":"2007","unstructured":"Anderson AC, Xiao S, Kuchroo VK (2007) Tim protein structures reveal a unique face for ligand binding. Immunity 26(3):273\u2013275","journal-title":"Immunity"},{"issue":"19","key":"2631_CR20","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1128\/MCB.05297-11","volume":"31","author":"J Lee","year":"2011","unstructured":"Lee J et al (2011) Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol Cell Biol 31(19):3963\u20133974","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2631_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2007.01.016","volume":"26","author":"E Cao","year":"2007","unstructured":"Cao E et al (2007) T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 26(3):311\u2013321","journal-title":"Immunity"},{"issue":"91","key":"2631_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0065-2776(06)91006-2","volume":"91","author":"VK Kuchroo","year":"2006","unstructured":"Kuchroo VK et al (2006) TIM family of genes in immunity and tolerance. Adv Immunol 91(91):227\u2013249","journal-title":"Adv Immunol"},{"key":"2631_CR23","doi-asserted-by":"publisher","unstructured":"Lv Y, Ma X, Ma Y, Du Y, Feng J. (2022) A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9). Genes Dis 10(6):2366-2382. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.020","DOI":"10.1016\/j.gendis.2022.05.020"},{"key":"2631_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101821","author":"R Yang","year":"2022","unstructured":"Yang R et al (2022) Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2022.101821","journal-title":"J Biol Chem"},{"issue":"6","key":"2631_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/cdd.2016.7","volume":"23","author":"S Nagata","year":"2016","unstructured":"Nagata S et al (2016) Exposure of phosphatidylserine on the cell surface. Cell Death Differ 23(6):952\u2013961","journal-title":"Cell Death Differ"},{"issue":"6","key":"2631_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2007.11.008","volume":"27","author":"C Santiago","year":"2007","unstructured":"Santiago C et al (2007) Structures of T cell immunoglobulin mucin protein 4 show a metal-ion-dependent ligand binding site where phosphatidylserine binds. Immunity 27(6):941\u2013951","journal-title":"Immunity"},{"issue":"7","key":"2631_CR27","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","volume":"148","author":"VA Fadok","year":"1992","unstructured":"Fadok VA et al (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148(7):2207\u20132216","journal-title":"J Immunol"},{"issue":"4","key":"2631_CR28","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.4049\/jimmunol.0903059","volume":"184","author":"RH DeKruyff","year":"2010","unstructured":"DeKruyff RH et al (2010) T cell\/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol 184(4):1918\u20131930","journal-title":"J Immunol"},{"issue":"7610","key":"2631_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature18317","volume":"535","author":"DC Avgousti","year":"2016","unstructured":"Avgousti DC et al (2016) A core viral protein binds host nucleosomes to sequester immune danger signals. Nature 535(7610):173\u2013177","journal-title":"Nature"},{"issue":"9","key":"2631_CR30","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba S et al (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13(9):832\u2013842","journal-title":"Nat Immunol"},{"issue":"4","key":"2631_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/hep.26938","volume":"59","author":"JS Dolina","year":"2014","unstructured":"Dolina JS, Braciale TJ, Hahn YS (2014) Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology 59(4):1351\u20131365","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"2631_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14357","volume":"54","author":"AK Gandhi","year":"2024","unstructured":"Gandhi AK et al (2024) Structural aspects of CEACAM1 interactions. Eur J Clin Invest 54(Suppl 2):e14357","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"2631_CR33","volume":"6","author":"M Dankner","year":"2017","unstructured":"Dankner M et al (2017) CEACAM1 as a multi-purpose target for cancer immunotherapy. Oncoimmunology 6(7):e1328336","journal-title":"Oncoimmunology"},{"issue":"12","key":"2631_CR34","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","volume":"50","author":"T Gayden","year":"2018","unstructured":"Gayden T et al (2018) Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet 50(12):1650\u20131657","journal-title":"Nat Genet"},{"issue":"4","key":"2631_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","volume":"3","author":"C Polprasert","year":"2019","unstructured":"Polprasert C et al (2019) Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood Adv 3(4):588\u2013595","journal-title":"Blood Adv"},{"issue":"6","key":"2631_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/08820139.2019.1599009","volume":"48","author":"R Zhang","year":"2019","unstructured":"Zhang R et al (2019) Association between T-cell immunoglobulin and mucin domain 3 (TIM-3) genetic polymorphisms and susceptibility to autoimmune diseases. Immunol Invest 48(6):563\u2013576","journal-title":"Immunol Invest"},{"issue":"3","key":"2631_CR37","first-page":"370","volume":"9","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Lee WY, Choe YH (2014) Expression of TIM-3, human \u03b2-defensin-2, and FOXP3 and correlation with disease activity in pediatric Crohn\u2019s disease with infliximab therapy. Gut Liver 9(3):370","journal-title":"Gut Liver"},{"issue":"3","key":"2631_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clim.2012.09.001","volume":"145","author":"F Shi","year":"2012","unstructured":"Shi F et al (2012) Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. Clin Immunol 145(3):230\u2013240","journal-title":"Clin Immunol"},{"issue":"2","key":"2631_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.clim.2009.09.012","volume":"134","author":"X Li","year":"2010","unstructured":"Li X et al (2010) Involvement of T cell Ig mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clin Immunol 134(2):169\u2013177","journal-title":"Clin Immunol"},{"issue":"9","key":"2631_CR40","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1002\/eji.201344392","volume":"44","author":"AS Gautron","year":"2014","unstructured":"Gautron AS et al (2014) Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol 44(9):2703\u20132711","journal-title":"Eur J Immunol"},{"key":"2631_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109645","volume":"115","author":"H Xiong","year":"2023","unstructured":"Xiong H et al (2023) Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS-and DSS-induced colitis in mice. Int Immunopharmacol 115:109645","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2631_CR42","first-page":"3809","volume":"8","author":"F Tang","year":"2015","unstructured":"Tang F et al (2015) Upregulation of Tim-3 on CD4+T cells is associated with Th1\/Th2 imbalance in patients with allergic asthma. Int J Clin Exp Med 8(3):3809","journal-title":"Int J Clin Exp Med"},{"issue":"18","key":"2631_CR43","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.1128\/JVI.00639-09","volume":"83","author":"L Golden-Mason","year":"2009","unstructured":"Golden-Mason L et al (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 83(18):9122\u20139130","journal-title":"J Virol"},{"issue":"1","key":"2631_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1465-9921-10-42","volume":"10","author":"F Idali","year":"2009","unstructured":"Idali F et al (2009) Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+T cells in sarcoidosis. Respir Res 10(1):42","journal-title":"Respir Res"},{"issue":"687","key":"2631_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aba0717","volume":"14","author":"S Kataoka","year":"2021","unstructured":"Kataoka S et al (2021) The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse. Sci Signal 14(687):eaba0717","journal-title":"Sci Signal"},{"issue":"905","key":"2631_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adk4594","volume":"18","author":"H Alamir","year":"2025","unstructured":"Alamir H et al (2025) TIM3 is a context-dependent coregulator of cytotoxic T cell function. Sci Signal 18(905):eadk4594","journal-title":"Sci Signal"},{"issue":"12","key":"2631_CR47","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.humimm.2004.07.002","volume":"65","author":"SC Chae","year":"2004","unstructured":"Chae SC et al (2004) The association of TIM-3 gene polymorphism with atopic disease in Korean population. Hum Immunol 65(12):1427\u20131431","journal-title":"Hum Immunol"},{"issue":"3","key":"2631_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000222677","volume":"150","author":"Q-W Wu","year":"2009","unstructured":"Wu Q-W et al (2009) Family-based association study of Tim-1 and Tim-3 gene polymorphisms with childhood asthma in Chinese trios. Int Arch Allergy Immunol 150(3):252\u2013260","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"2631_CR49","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.humimm.2011.04.007","volume":"72","author":"YW Song","year":"2011","unstructured":"Song YW et al (2011) T-cell immunoglobulin and mucin domain 3 genetic polymorphisms are associated with rheumatoid arthritis independent of a shared epitope status. Hum Immunol 72(8):652\u2013655","journal-title":"Hum Immunol"},{"issue":"6","key":"2631_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1744-313X.2011.01046.x","volume":"38","author":"J Xu","year":"2011","unstructured":"Xu J et al (2011) The\u2212 1541 C> T and+ 4259 G> T of TIM-3 polymorphisms are associated with rheumatoid arthritis susceptibility in a Chinese Hui population. Int J Immunogenet 38(6):513\u2013518","journal-title":"Int J Immunogenet"},{"issue":"6","key":"2631_CR51","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181235","volume":"38","author":"R Liu","year":"2018","unstructured":"Liu R et al (2018) TIM-3 rs1036199 polymorphism increases susceptibility to autoimmune diseases: evidence based on 4200 subjects. Biosci Rep 38(6):BSR20181235","journal-title":"Biosci Rep"},{"key":"2631_CR52","doi-asserted-by":"publisher","first-page":"1482213","DOI":"10.3389\/fimmu.2024.1482213","volume":"15","author":"J Ke","year":"2024","unstructured":"Ke J et al (2024) Nfil3\/Tim3 axis regulates effector Th1 inflammation in COPD mice. Front Immunol 15:1482213","journal-title":"Front Immunol"},{"key":"2631_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.770402","volume":"12","author":"L Tang","year":"2022","unstructured":"Tang L et al (2022) Tim-3 relieves experimental autoimmune encephalomyelitis by suppressing MHC-II. Front Immunol 12:770402","journal-title":"Front Immunol"},{"issue":"2","key":"2631_CR54","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1210\/en.2011-1579","volume":"153","author":"M Kanzaki","year":"2012","unstructured":"Kanzaki M et al (2012) Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Endocrinology 153(2):612\u2013620","journal-title":"Endocrinology"},{"issue":"11","key":"2631_CR55","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni987","volume":"4","author":"A S\u00e1nchez-Fueyo","year":"2003","unstructured":"S\u00e1nchez-Fueyo A et al (2003) Tim-3 inhibits T helper type 1\u2013mediated auto-and alloimmune responses and promotes immunological tolerance. Nat Immunol 4(11):1093\u20131101","journal-title":"Nat Immunol"},{"issue":"5","key":"2631_CR56","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/2211-5463.13148","volume":"11","author":"H Wu","year":"2021","unstructured":"Wu H et al (2021) Tim-3 suppresses autoimmune hepatitis via the p38\/MKP-1 pathway in Th17 cells. FEBS Open Bio 11(5):1406\u20131416","journal-title":"FEBS Open Bio"},{"issue":"6","key":"2631_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28302","volume":"67","author":"O Wegehaupt","year":"2020","unstructured":"Wegehaupt O et al (2020) TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 67(6):e28302","journal-title":"Pediatr Blood Cancer"},{"key":"2631_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103072","author":"F Wang","year":"2024","unstructured":"Wang F et al (2024) Macrophage Tim-3 maintains intestinal homeostasis in DSS-induced colitis by suppressing neutrophil necroptosis. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2024.103072","journal-title":"Redox Biol"},{"key":"2631_CR59","doi-asserted-by":"publisher","first-page":"1183326","DOI":"10.3389\/fmed.2023.1183326","volume":"10","author":"D Lin","year":"2023","unstructured":"Lin D et al (2023) Association of TIM-3 with anterior uveitis and associated systemic immune diseases: a Mendelian randomization analysis. Front Med 10:1183326","journal-title":"Front Med"},{"issue":"1","key":"2631_CR60","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah K et al (2021) T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther 6(1):412","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2631_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","volume":"6","author":"Z Yan","year":"2025","unstructured":"Yan Z et al (2025) TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives. Mol Biomed 6(1):27","journal-title":"Mol Biomed"},{"key":"2631_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","volume":"510","author":"S Kandel","year":"2021","unstructured":"Kandel S et al (2021) The TIM3\/Gal9 signaling pathway: an emerging target for cancer immunotherapy. Cancer Lett 510:67\u201378","journal-title":"Cancer Lett"},{"issue":"2","key":"2631_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4049\/jimmunol.1302663","volume":"192","author":"KL Clayton","year":"2014","unstructured":"Clayton KL et al (2014) T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases. J Immunol 192(2):782\u2013791","journal-title":"J Immunol"},{"issue":"10","key":"2631_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140694","volume":"10","author":"B Tomkowicz","year":"2015","unstructured":"Tomkowicz B et al (2015) TIM-3 suppresses anti-CD3\/CD28-induced TCR activation and IL-2 expression through the NFAT signaling pathway. PLoS ONE 10(10):e0140694","journal-title":"PLoS ONE"},{"issue":"10","key":"2631_CR65","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.imbio.2012.01.012","volume":"217","author":"MJ Lee","year":"2012","unstructured":"Lee MJ et al (2012) Down-regulation of interleukin-2 production by CD4+T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription. Immunobiology 217(10):986\u2013995","journal-title":"Immunobiology"},{"issue":"12","key":"2631_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/ni739","volume":"2","author":"JJ McIntire","year":"2001","unstructured":"McIntire JJ et al (2001) Identification of (an airway hyperreactivity regulatory locus) and the linked gene family. Nat Immunol 2(12):1109\u20131116","journal-title":"Nat Immunol"},{"key":"2631_CR67","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00109-020-01958-z","volume":"98","author":"KS Lechner","year":"2020","unstructured":"Lechner KS, Neurath MF, Weigmann B (2020) Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis. J Mol Med 98:1385\u20131395","journal-title":"J Mol Med"},{"issue":"4","key":"2631_CR68","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/j.gastro.2021.06.072","volume":"161","author":"K Lechner","year":"2021","unstructured":"Lechner K et al (2021) Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis. Gastroenterology 161(4):1270","journal-title":"Gastroenterology"},{"issue":"8","key":"2631_CR69","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/eji.201445087","volume":"45","author":"A Kannan","year":"2015","unstructured":"Kannan A et al (2015) Allele-sensitive mutant, Itkas, reveals that Itk kinase activity is required for Th1, Th2, Th17, and iNKT-cell cytokine production. Eur J Immunol 45(8):2276\u20132285","journal-title":"Eur J Immunol"},{"issue":"6","key":"2631_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14304\/SURYA.JPR.V2N6.1","volume":"2","author":"Y Zhong","year":"2014","unstructured":"Zhong Y et al (2014) Targeting interleukin-2-inducible T-cell kinase (ITK) in T-cell related diseases. Postdoc J 2(6):1\u201311","journal-title":"Postdoc J"},{"issue":"8","key":"2631_CR71","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.4049\/jimmunol.1102609","volume":"188","author":"S Mujib","year":"2012","unstructured":"Mujib S et al (2012) Antigen-independent induction of Tim-3 expression on human T cells by the common \u03b3-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway. J Immunol 188(8):3745\u20133756","journal-title":"J Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02631-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02631-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02631-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:03:46Z","timestamp":1767463426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02631-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2631"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02631-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"20"}}